这是一篇来自已证抗体库的有关人类 TNFRSF11A的综述,是根据7篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合TNFRSF11A 抗体。
TNFRSF11A 同义词: CD265; FEO; LOH18CR1; ODFR; OFE; OPTB7; OSTS; PDB2; RANK; TRANCER; tumor necrosis factor receptor superfamily member 11A; Paget disease of bone 2; loss of heterozygosity, 18, chromosomal region 1; osteoclast differentiation factor receptor; receptor activator of NF-KB; receptor activator of nuclear factor-kappa B; tumor necrosis factor receptor superfamily, member 11a, NFKB activator

艾博抗(上海)贸易有限公司
小鼠 单克隆(64C1385)
  • 流式细胞仪; 人类; 1:50; 图 1b
  • 流式细胞仪; 小鼠; 1:50; 图 1b
艾博抗(上海)贸易有限公司 TNFRSF11A抗体(Abcam, ab13918)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 1b) 和 被用于流式细胞仪在小鼠样本上浓度为1:50 (图 1b). Bone Res (2018) ncbi
兔 多克隆
艾博抗(上海)贸易有限公司 TNFRSF11A抗体(Abcam, ab200369)被用于. Bone Res (2018) ncbi
小鼠 单克隆(64C1385)
  • 免疫组化-石蜡切片; 人类; 1:200; 图 1a
艾博抗(上海)贸易有限公司 TNFRSF11A抗体(Abcam, AB13918)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 1a). Oral Surg Oral Med Oral Pathol Oral Radiol (2015) ncbi
安迪生物R&D
小鼠 单克隆(80704)
  • 流式细胞仪; 人类; 图 1e, 1f
安迪生物R&D TNFRSF11A抗体(R&D Systems, FAB683P)被用于被用于流式细胞仪在人类样本上 (图 1e, 1f). Cell Death Dis (2017) ncbi
小鼠 单克隆(80704)
  • 免疫组化-石蜡切片; 人类
安迪生物R&D TNFRSF11A抗体(R&D Systems, MAB683)被用于被用于免疫组化-石蜡切片在人类样本上. Clin Breast Cancer (2015) ncbi
Novus Biologicals
小鼠 单克隆(9A725)
  • 免疫印迹; 小鼠; 图 4
Novus Biologicals TNFRSF11A抗体(Novus Biologicals, NB100-56508)被用于被用于免疫印迹在小鼠样本上 (图 4). J Dent Res (2016) ncbi
圣克鲁斯生物技术
小鼠 单克隆(9A725)
  • 免疫组化-石蜡切片; 人类; 1:500; 图 1
圣克鲁斯生物技术 TNFRSF11A抗体(santa Cruz, sc-52951)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500 (图 1). Oncotarget (2015) ncbi
赛默飞世尔
小鼠 单克隆(9A725)
  • 流式细胞仪; 小鼠; 图 5
赛默飞世尔 TNFRSF11A抗体(Thermo Fisher Scientific, 9A725)被用于被用于流式细胞仪在小鼠样本上 (图 5). Sci Rep (2015) ncbi
文章列表
  1. Chen X, Zhi X, Wang J, Su J. RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation. Bone Res. 2018;6:34 pubmed 出版商
  2. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed 出版商
  3. Huynh N, VonMoss L, Smith D, Rahman I, Felemban M, Zuo J, et al. Characterization of Regulatory Extracellular Vesicles from Osteoclasts. J Dent Res. 2016;95:673-9 pubmed 出版商
  4. Wang B, Jin H, Shu B, Mira R, Chen D. Chondrocytes-Specific Expression of Osteoprotegerin Modulates Osteoclast Formation in Metaphyseal Bone. Sci Rep. 2015;5:13667 pubmed 出版商
  5. Zhang L, Teng Y, Fan Y, Wang Y, Li W, Shi J, et al. The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis. Oncotarget. 2015;6:22918-33 pubmed
  6. Siar C, Tsujigiwa H, Ishak I, Hussin N, Nagatsuka H, Ng K. RANK, RANKL, and OPG in recurrent solid/multicystic ameloblastoma: their distribution patterns and biologic significance. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119:83-91 pubmed 出版商
  7. Labovsky V, Martinez L, Davies K, Garcia Rivello H, Calcagno M, Matas A, et al. Association between ligands and receptors related to the progression of early breast cancer in tumor epithelial and stromal cells. Clin Breast Cancer. 2015;15:e13-21 pubmed 出版商